The Central Commission for Discipline Inspection named medical corruption! Who's next to be "squeezed"?

The Central Commission for Discipline Inspection issued a document directly named corruption in the field of medicine.
particularly noteworthy at a time when heart stents are "squeezing water" and "big price cuts."
10, the Central Commission for Discipline Inspection issued an opinion article entitled "Promoting the health care industry in a multi-pronged way" on the website of the State Supervision Commission of the Central Commission for Discipline Inspection. The article refers directly to the
case of high amounts, corruption interest chain, a large number of disclosed cases of corruption in the medical field, the collection of drug supplies rebate problem appears the most frequently, resulting in high prices of drugs and medical supplies, medical costs too fast growth, loss of health insurance funds and other issues, increasing the burden of patients, infringing on the vital interests of the people." The
" article goes on to mention that corruption and misconduct in the medical field have always been a strong focus of public reaction, and discipline inspection and supervision organs at all levels, based on their functional responsibilities, closely follow the risk points and high-risk links of integrity in the medical field, seriously investigate and punish leading cadres and public officials of Party members who violate discipline and law, and resolutely cut off the chain of corrupt interests.
two typical cases of corruption in the procurement of pharmaceutical supplies are listed in two typical cases of corruption in the procurement of pharmaceuticals and medical equipment.
In January 2020, the People's Court of Luxian County, Zhejiang Province, issued a criminal judgment showing that Wang Xiaojun, a pharmacist in the Pharmacy Department of the First People's Hospital of Yixian County, used the hospital's drug information, was responsible for the initial nuclear treatment of new drugs, and daily procurement. In cooperation with Pan Xinhua in the introduction of new drugs, drug procurement and other aspects for a number of pharmaceutical enterprises to seek benefits, illegal receipt of drug dealers "kickbacks" of more than 10.19 million yuan, and the distribution of stolen goods, Wang Xiaojun alone received rebates of 183.81 million yuan.
In addition, Wang Xiaojun, together with Lei, head of the maintenance team of the Information Section of the Central Hospital of Luxian County, used Lei's position in charge of managing the computer information system of the Central Hospital of Luxian County to help drug sales personnel obtain data on prescription drug use and illegally receive benefits.
In the end, the court sentenced Wang Xiaojun to 12 years and 6 months in prison and a fine of 2 million yuan;
cases of corruption in the procurement of medical equipment, the medical personnel involved in the case are "falling into the abyss of corruption step by step".
November 2019, the Chengdu Commission for Discipline Inspection issued a circular informing the director of the Equipment and Materials Supply Section of the First People's Hospital of Longquan District, Who is under disciplinary review and supervision investigation for serious disciplinary violations.
Subsequent investigations revealed that, in violation of the spirit and integrity discipline of the eight central provisions, Toquanyu received red envelope gifts from management objects, took official opportunities to change the route of tourism, violated integrity discipline, accepted tourism activities that may affect the fair performance of official duties, violated the provisions of state laws and regulations, took advantage of the convenience of his position, took illegal measures for the relevant personnel in the supply of drugs, equipment procurement and other aspects of profit, accept bribes of more than 680,000 yuan.
administrative power has been reduced to a "pass" for The Capital Springs to seize windfall profits.
" our investigation found that The long-term in key positions, in a variety of interests and hunting, from receiving hundreds of yuan red envelopes to a one-time bribe of 100,000 yuan, step by step into the abyss of corruption, a total of more than 680,000 yuan in bribes.
", Chengdu Commission for Discipline Inspection, the relevant person in charge of the introduction.
January 2020, Mr. Tsing-yu was expelled from the Party and dismissed from public office for serious disciplinary violations.
2020, Mr. Yu was sentenced to three years in prison and fined 200,000 yuan for taking bribes.
cases of such corruption, the Central Commission for Discipline Inspection pointed out in the article that the investigation and prosecution of cases played a warning, deterrent role, heavy-handed fight against disciplinary violations in the medical field can not be loose, can not be soft.
, we should also work the system and governance, strengthen the restriction and supervision of the operation of power, and promote the multi-pronged construction of comprehensive governance system.
The source of the fight against corruption Industry has begun to focus on the recent huge decline caused by the hot discussion of the crown stent belt volume procurement, the Central Commission for Discipline Inspection said in the article, this is the continuous efforts to deepen the reform of the centralized procurement system of pharmaceutical supplies for patients to bring benefits, but also a multi-pronged effort to promote the health care industry is one of the important measures.
, reforming the procurement mechanism for medicines and medical supplies is considered an important step in source governance.
What needs to be seen is that the purchase of drugs and consumables by the state to pharmaceutical enterprises directly tender, the winning drug and consumables product volume prices linked, small profits and sales, in the middle of the savings of huge sales costs, to promote price return to a reasonable level.
three years since the introduction of drug belt procurement, the average price reduction of selected drugs has reached 54%.
For the crown bracket huge price reduction, the text pointed out that the difference between the past 13,000 yuan, in fact, in the past in the sales link increased "water", but also easy to trigger violations of the "grey space."
According to rough media statistics, in 2019, more than 300 listed pharmaceutical companies sales costs more than 250 billion yuan, which is how much water can be squeezed out, giving people a lot of room for imagination.
and most of the crown bracket enterprises reported more than 700 yuan price, and did not lose money, in fact, "has fully taken into account the cost and profit level of the enterprise."
" With the continuous promotion of reform measures and the landing of supervision, pharmaceutical enterprises old sales model on the development of the medical industry will be greatly reduced, the enterprise's previously much-maligned "gold sales" model is the end of the road, we must find a new way.
enterprises to fight quality, hard research and development, hard innovation is the right way, the vital interests of patients will also be better maintained.
It is worth noting that just one week after the results of the proposed selection of crown belt volume procurement were announced, the State Drug Administration issued a "notice on strengthening the quality supervision of crown veins in national centralized belt procurement", echoing before and after the volume procurement negotiations, to strengthen production supervision for selected enterprises, and effectively ensure the quality and safety of centralized belt procurement crown stents.
Focus on promoting the reform of medical service prices At present, the national medical and health industry is carrying out special actions in the construction of style, focusing on punishing improper acts such as using their positions to facilitate the receipt of red envelopes, cracking down on illegal and illegal acts of collecting kickbacks, and seriously investigating and punishing illegal marketing practices of pharmaceutical products in medical institutions.
the state has put in place a number of policies to crack down on kickbacks and medical corruption.
The State Health Insurance Administration issued the Guidance on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment, and pharmaceutical enterprises involved in seven types of disrelieving acts, such as commercial bribery of medicines, will be included in the "black list" of disrelieving.
Supreme People's Court and the State Administration of Health Insurance signed the Memorandum of Cooperation on the Exchange and Sharing of Information on Commercial Bribery Cases in the Pharmaceutical Field, established a regular notification system, and continuously deepened cooperation in the management of commercial bribery in the pharmaceutical field.
multi-sector linkage, playing a series of combination punches, aimed at rooting out the pharmaceutical bidding or procurement process in the process of profit transmission, covert operation, false price increases and other outstanding issues.
The article of the Central Commission for Discipline Inspection stressed at the end that, in order to establish a clean industry environment, on the one hand, we should strengthen the ideological education of medical industry personnel, carry out in-depth education on integrity, tighten the "total switch" of faith awareness, on the other hand, we should also focus on promoting the reform of medical service prices, so that doctors' wisdom, medical technology reflects its due value, so that medical workers' services can obtain a reasonable price level.